The operating theatre of the future: What will it look like in 2050?

The dawn of nanorobotics marks a pivotal transformation in tissue-specific drug delivery, enhancing the precision and efficiency of surgical interventions (Li, 2017). This innovative approach involves transporting therapeutics, including potent analgesia and anticancer agents directly to sites of disease using magnetic fields (Kim DI, 2020) and electrochemical gradients to steer nanorobotic motors. Notably, the use of magneto-aerotactic bacteria to guide drug-loaded nanoliposomes to hypoxic tumour sites showcases the remarkable precision achievable, offering hope for neo-adjunctively reducing tumour sizes while limiting systemic side effects (Felfoul O, 2016).

The battle against bacterial biofilms is a formidable challenge in orthopaedics, often necessitating the removal of implants. Nanotechnology is a powerful ally, with advancements focusing on anti-biofilm implants guarded with nanoparticles. Unlike traditional titanium implants, these coated with silver nanopowder are significantly less susceptible to microbial colonisation (Kose N, 2016). The superior attributes of silver nanoparticles are not only in their antibacterial and anti-inflammatory properties (Smith WR, 2018) but in their ability to promote osteoblast activity and proliferation, resulting in improved osteointegration (Karazisis D, 2016), a critical factor for implant longevity and success. Nanotechnology's inherent high surface area to volume ratio maximises efficacy with minimal material use, marking a significant stride towards safer, more effective orthopaedic treatments.

The future operating theatres are imagined as smart, adaptive ecosystems that proactively support surgical teams during demanding situations. These theatres, equipped with cutting-edge sensors and AI, intelligently analyse real-time data to identify potential risks and automatically adapt to the environment cooling temperatures for a refreshing atmosphere, playing relaxing music to alleviate stress and increasing operational site lighting for improved visibility. Additionally, to minimise external distractions, visual screens provide reminders that critical procedures are underway. This configuration is designed to support surgeons in high-pressure scenarios, enhance patient outcomes, and streamline the surgical process by smartly adjusting environmental factors and minimising distractions at crucial moments.

Integrating augmented reality (AR) headsets in surgical operations can considerably improve procedural efficiency and enrich the learning experience for medical students. These headsets, offer an immersive visualisation of the operating field, merging vital patient records and radiological images directly into the surgeon's field of view, guiding them through each critical phase of the operation (Allen, 2023). For medical students, this AR technology proves revolutionary, highlighting key anatomical structures and surgical techniques in real time. This not only enhances their understanding of complex procedures but also deepens their anatomical knowledge, making it a fundamental tool in surgical education (Varjo,UNKNOWN)

These headsets also facilitate direct, real-time communication with expert surgeons around the globe (Esposito, 2022). Through this technology, remote surgeons can contribute actively during procedures, providing real-time insights, and structural identifications, thereby enhancing decision-making. Indeed, these headsets represent a cornerstone for future surgical theatres, leading the charge towards a more interconnected, collaborative global surgical community while elevating the quality of patient care.

The next quarter century may bring significant advancements in robotic autonomy. While it remains uncertain if robots will achieve the intellectual capacity to operate independently, the synergy between human surgeons and robotic systems is set to deepen. A notable breakthrough could entail a brain-to-robot interface (Vilela M, 2020), enabling surgeons to seamlessly guide and interact with robotic aids through verbal commands or mental visualisation (Cao L, 2021). This fusion of human intuition and robotic precision could dramatically expand the possibilities of surgical care, making procedures safer, faster, and more effective. Such technology marries the surgeon’s experience and knowledge with tireless, precise robotics capabilities to redefine the surgical intervention landscape.

Enhancing the sustainability of operating theatres is essential for reducing the surgical carbon footprint. A key strategy involves harnessing natural daylight through installing translucent skylights which provide ample lighting while maintaining patient privacy. This approach reduces reliance on artificial lighting and enhances staff and patient wellbeing (Wang J, 2023). Furthermore, converting the kinetic energy from surgical teams’ movements into electricity can power lights and equipment, integrating human activity as a renewable energy source and diminishing fossil fuel dependency (Energy Floors, 2023). Additionally, the healthcare system, primarily through the use of anaesthetic gases, contributes significantly to global greenhouse gas emissions, exceeding those of aviation and shipping combined. Implementing a capture and recycling system, which can reuse about 90% of filtered gases, offers a critical solution for more sustainable anaesthetic practices. Together these initiatives advance operating theatres towards being technologically innovative and environmentally conscious, establishing a new standard for sustainable surgery.

Merging 3D printing with bioengineering generates patient-specific tissues while ensuring immunological compatibility. This innovative approach aims to eliminate transplant rejection, reduce reliance on immunosuppressive medications, and shorten transplant waiting lists. A pioneering example is the bio-printed cardiac patch, cultured from mesenchymal stem cells and endothelial cells, successfully implanted into infarcted areas of rat hearts. This study highlighted the potential of 3D bioprinting in promoting angiogenesis and cardiac tissue regeneration post-infarction (Saini G, 2021), marking a new era in personalised and regenerative medicine. It signifies a transformative shift towards a future where patients themselves become the source of their therapeutic surgical solutions.

As years progress, the surgical landscape promises remarkable advancements, from nanorobotics to ecofriendly practices and beyond. As we embrace these new technologies, we must safeguard our core values of serving and respecting the patients entrusted to our care.